A chemical compound that boosts the action of a molecule normally produced in the brain may provide the starting point for a new line of therapies for the treatment of epileptic seizures, according to a new study by scientists at The Scripps Research Institute.
Thursday, July 29, 2010 - 13:55
The experiment demonstrated the feasibility of an approach to growing dissimilar tissues, such as cartilage and bone, derived entirely from the host’s own cells. Results of the study are in the July 29 issue of The Lancet.
Thursday, July 29, 2010 - 08:43
Scientists at the Stanford University School of Medicine have identified a molecular pathway responsible for the death of key nerve cells whose loss causes Parkinson’s disease. This discovery not only may explain how a genetic mutation linked to Parkinson’s causes the cells’ death, but could also open the door to new therapeutic approaches for the malady.
Wednesday, July 28, 2010 - 13:09
Scientists have developed a new version of a medication, first isolated from the saliva of sea snails, that could be taken in pill form to relieve the most severe forms of pain as effectively as morphine but without risking addiction.
Wednesday, July 28, 2010 - 13:00
A combination of nutrients called NT-020 promoted adult neural stem cell proliferation in aged rats and boosted their memory performance, reported University of South Florida researchers studying natural therapeutic approaches to promoting the health of neurons in the aging brain. Researchers from the USF Department of Neurosurgery and Brain Repair tested two groups of aged laboratory rats; one group received NT-020 and another, the control group, did not. In the NT-020 group, the process by which neurons are generated -- called neurogenesis -- increased.
Wednesday, July 21, 2010 - 11:02
If mice are administered an antibiotic for three days and are simultaneously infected with malaria, no parasites appear in the blood and life-threatening disease is averted. In addition, the animals treated in this manner also develop robust, long-term immunity against subsequent infections.
Wednesday, July 21, 2010 - 10:51
In the initial stages of sleep, energy levels increase dramatically in brain regions found to be active during waking hours, according to new research in the June 30 issue of The Journal of Neuroscience. These results suggest that a surge of cellular energy may replenish brain processes needed to function normally while awake.
Tuesday, July 6, 2010 - 10:37
Those looking for a new treatment for a range of inflammatory diseases like arthritis, multiple sclerosis, inflammatory bowel disease, and lupus may need to look no further than a drug already available for treating cancer.
Thursday, July 1, 2010 - 11:40
The landmark discovery found that injection of an agent called 'ADAC', activates adenosine receptors in cochlear tissues, resulting in recovery of hearing function. The finding paves the way for effective non-surgical therapies to restore hearing loss after noise-induced injury.
Thursday, July 1, 2010 - 11:05
Progress toward understanding the role of sex hormones in the growth of prostate cancer—the most common cancer in U.S. men—has been hindered by the lack of a suitable laboratory research model. Now researchers say they have developed the first model of hormone-induced human prostate cancer initiation and progression.
Thursday, July 1, 2010 - 11:00
Crayfish make surprisingly complex, cost-benefit calculations, finds a University of Maryland study -- opening the door to a new line of research that may help unravel the cellular brain activity involved in human decisions.
Monday, June 28, 2010 - 10:01
Mice with a gene variant linked to Crohn's disease only develop the inflammatory bowel disorder if they are infected by a common norovirus called MNV, finds a new study.
Friday, June 25, 2010 - 10:15
The vitamin folate appears to promote healing in damaged rat spinal cord tissue by triggering a change in DNA, according to a laboratory study funded by the National Institutes of Health. The researchers showed that the healing effects of the vitamin increased with the dosage, until regrowth of the damaged tissue reached a maximum level.
Thursday, June 24, 2010 - 12:56
A protein whose primary role is in the embryonic development of kidneys may play a future role in treating kidney failure. Indiana University School of Medicine researchers have successfully treated acute kidney injury in laboratory experiments using cells that were genetically reprogrammed to produce the protein.
Wednesday, June 23, 2010 - 13:10
A synthetic version of a naturally occurring peptide promoted the creation of new blood vessels and repaired damaged nerve cells in lab animals, according to researchers at Henry Ford Hospital in Detroit.
Tuesday, June 22, 2010 - 10:58
Researchers have found that increasing certain proteins in the blood vessels of mice, relaxed the vessels, lowering the animal’s blood pressure. The study provides new avenues for research that may lead to new treatments for hypertension.
Tuesday, June 22, 2010 - 10:43
A single species of bacteria that lives in the gut is able to trigger a cascade of immune responses that can ultimately result in the development of arthritis.
Monday, June 21, 2010 - 11:44
Researchers have developed an experimental cure for Type 1 diabetes, a disease that affects about one in every 400 to 600 children and adolescents.
Monday, June 21, 2010 - 10:43
Children who suffer from the devastating disease Spinal Muscular Atrophy are set to benefit from a new breakthrough in therapy developments by researchers at the University of Sheffield.
Thursday, June 10, 2010 - 12:53
Dr. Kelvin Jones is looking at exercise as a new way to slow the degenerative processes of ALS, commonly known as Lou Gehrig’s disease. Jones, a recipient of a 2009 ALS Canada Discovery Grant, has been pioneering research in this field for four years, using mice genetically altered to present familial ALS. He’s found that exercise has a positive impact on the mice, slowing the disease significantly.
Wednesday, June 9, 2010 - 10:49